What is Jeffrey W. Albers J.D., M.B.A., MBA net worth?
The estimated net worth of Mr. Jeffrey W. Albers J.D., M.B.A., MBA is at least $90,793,579 as of 7 Nov 2024. He owns shares worth
$20,397,329 as insider, has earned $58,396,250
from insider trading and has received compensation worth at least
$12,000,000 in Blueprint Medicines Corporation.
What is the salary of Jeffrey W. Albers J.D., M.B.A., MBA?
Mr. Jeffrey W. Albers J.D., M.B.A., MBA salary is $1,200,000 per year
as Chairman, Chief Executive Officer & Pres in Blueprint Medicines Corporation.
How old is Jeffrey W. Albers J.D., M.B.A., MBA?
Mr. Jeffrey W. Albers J.D., M.B.A., MBA is 54 years old, born in 1971.
What stocks does Jeffrey W. Albers J.D., M.B.A., MBA currently own?
As insider, Mr. Jeffrey W. Albers J.D., M.B.A., MBA owns shares in one company:
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally available and potent inhibitor for the treatment of hepatocellular carcinoma. It is also developing GAVRETO for the treatment of RET fusion-positive non-small cell lung cancer, altered solid tumors, medullary thyroid carcinoma, and other solid tumors; BLU-701 and BLU-945 for the treatment of epidermal growth factor receptor driven non-small-cell lung carcinoma (NSCLC); and BLU-451 to treat NSCLC in patients with epidermal growth factor receptor gene (EGFR) exon 20 insertion mutations. In addition, the company is developing BLU-782, for the treatment of fibrodysplasia ossificans progressive; BLU- 222 to treat patients with cyclin E aberrant cancers; and BLU-852 for the treatment of advanced cancers. It has collaboration and license agreements with Clementia Pharmaceuticals, Inc.; Proteovant Therapeutics; CStone Pharmaceuticals; Genentech, Inc.; F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and Zai Lab (Shanghai) Co., Ltd. The company was formerly known as Hoyle Pharmaceuticals, Inc. and changed its name to Blueprint Medicines Corporation in June 2011. Blueprint Medicines Corporation was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.
Jeffrey W. Albers J.D., M.B.A., MBA insider trading
Blueprint Medicines Corporation
Mr. Jeffrey W. Albers J.D., M.B.A., MBA has made 78 insider trades between 2015-2024, according to the Form 4 filled with the SEC.
The largest trade he's
ever made was exercising 40,000 units of BPMC stock
on 23 Mar 2020. As of 7 Nov 2024
he still owns at least 157,557 units of BPMC stock.
Transaction
Date
Security
Shares
Price per share
Total value
Source
Option
Common Stock
5,000
$36.05
$180,250
Option
Stock Option (Right to Buy)
5,000
$36.05
$180,250
Sale
Common Stock
5,000
$102
$510,000
Option
Stock Option (Right to Buy)
10,000
$36.05
$360,500
Option
Common Stock
10,000
$36.05
$360,500
Sale
Common Stock
7,734
$85.12
$658,318
Sale
Common Stock
11,968
$85.86
$1,027,572
Option
Stock Option (Right to Buy)
25,073
$8.44
$211,616
Sale
Common Stock
2,730
$85.22
$232,651
Option
Common Stock
15,073
$1.87
$28,187
Option
Common Stock
10,000
$15.01
$150,100
Sale
Common Stock
8,440
$87.26
$736,474
Sale
Common Stock
6,251
$86.46
$540,461
Sale
Common Stock
1,367
$89.12
$121,827
Sale
Common Stock
6,285
$88.6
$556,851
Sale
Common Stock
11,033
$90.69
$1,000,583
Sale
Common Stock
100
$83.57
$8,357
Option
Common Stock
15,000
$1.87
$28,050
Option
Stock Option (Right to Buy)
10,000
$15.01
$150,100
Option
Stock Option (Right to Buy)
15,000
$1.87
$28,050
Sale
Common Stock
6,086
$81.16
$493,940
Sale
Common Stock
10,890
$81.7
$889,713
Sale
Common Stock
7,924
$82.76
$655,790
Option
Common Stock
10,000
$15.01
$150,100
Option
Stock Option (Right to Buy)
5,000
$36.05
$180,250
Sale
Common Stock
5,000
$79.07
$395,350
Option
Common Stock
5,000
$36.05
$180,250
Sale
Common Stock
1,485
$60.13
$89,293
Option
Stock Option (Right to Buy)
1,485
$36.05
$53,534
Option
Common Stock
1,485
$36.05
$53,534
Option
Common Stock
4,634
$36.05
$167,056
Sale
Common Stock
59
$61.05
$3,602
Sale
Common Stock
4,575
$60.36
$276,147
Option
Stock Option (Right to Buy)
4,634
$36.05
$167,056
Option
Common Stock
3,881
$36.05
$139,910
Option
Stock Option (Right to Buy)
3,881
$36.05
$139,910
Sale
Common Stock
3,881
$60.02
$232,938
Option
Common Stock
6,898
$1.87
$12,899
Sale
Common Stock
6,898
$50.17
$346,073
Option
Stock Option (Right to Buy)
6,898
$1.87
$12,899
Option
Common Stock
18,102
$1.87
$33,851
Sale
Common Stock
12,102
$49.93
$604,253
Option
Stock Option (Right to Buy)
18,102
$1.87
$33,851
Sale
Common Stock
400
$50.5
$20,200
Sale
Common Stock
5,600
$48.84
$273,504
Option
Stock Option (Right to Buy)
10,000
$1.87
$18,700
Sale
Common Stock
10,000
$50.16
$501,600
Option
Common Stock
10,000
$1.87
$18,700
Option
Common Stock
15,000
$1.87
$28,050
Option
Stock Option (Right to Buy)
15,000
$1.87
$28,050
Sale
Common Stock
15,000
$49.57
$743,550
Sale
Common Stock
9,474
$45.72
$433,151
Sale
Common Stock
319
$44.27
$14,122
Sale
Common Stock
20,000
$50.09
$1,001,800
Option
Stock Option (Right to Buy)
10,000
$15.01
$150,100
Option
Common Stock
10,000
$15.01
$150,100
Option
Common Stock
10,000
$1.87
$18,700
Option
Stock Option (Right to Buy)
10,000
$1.87
$18,700
Option
Stock Option (Right to Buy)
8,410
$15.01
$126,234
Sale
Common Stock
662
$71.3
$47,201
Option
Common Stock
8,410
$15.01
$126,234
Sale
Common Stock
7,748
$70.47
$546,002
Sale
Common Stock
1,590
$70.02
$111,332
Option
Stock Option (Right to Buy)
1,590
$15.01
$23,866
Option
Common Stock
1,590
$15.01
$23,866
Sale
Common Stock
12,477
$68.62
$856,172
Option
Stock Option (Right to Buy)
10,000
$15.01
$150,100
Sale
Common Stock
293
$69.52
$20,369
Sale
Common Stock
7,230
$68.01
$491,712
Option
Common Stock
10,000
$1.87
$18,700
Option
Stock Option (Right to Buy)
10,000
$1.87
$18,700
Option
Common Stock
10,000
$15.01
$150,100
Option
Stock Option (Right to Buy)
7,170
$8.8
$63,096
Option
Stock Option (Right to Buy)
2,830
$1.87
$5,292
Option
Common Stock
7,170
$8.8
$63,096
Option
Common Stock
2,830
$1.87
$5,292
Sale
Common Stock
10,000
$70.07
$700,700
Sale
Common Stock
5,342
$55.63
$297,175
Option
Stock Option (Right to Buy)
10,000
$15.01
$150,100
Sale
Common Stock
1,900
$54.48
$103,512
Option
Stock Option (Right to Buy)
10,000
$1.87
$18,700
Option
Common Stock
10,000
$15.01
$150,100
Option
Common Stock
10,000
$1.87
$18,700
Sale
Common Stock
12,758
$56.21
$717,127
Option
Stock Option (Right to Buy)
5,000
$15.01
$75,050
Sale
Common Stock
5,000
$70.11
$350,550
Option
Common Stock
5,000
$15.01
$75,050
Sale
Common Stock
4,843
$56.19
$272,128
Option
Stock Option (Right to Buy)
7,500
$1.87
$14,025
Option
Stock Option (Right to Buy)
12,500
$15.01
$187,625
Option
Common Stock
7,500
$1.87
$14,025
Sale
Common Stock
4,100
$58.28
$238,948
Sale
Common Stock
1,400
$59.43
$83,202
Sale
Common Stock
10,055
$56.61
$569,214
Option
Common Stock
12,500
$15.01
$187,625
Sale
Common Stock
4,445
$57.66
$256,299
Sale
Common Stock
7,862
$60.28
$473,921
Option
Common Stock
30,000
$8.44
$253,200
Option
Stock Option (Right to Buy)
30,000
$8.44
$253,200
Sale
Common Stock
30,000
$113.51
$3,405,300
Option
Stock Option (Right to Buy)
5,000
$15.01
$75,050
Option
Common Stock
5,000
$15.01
$75,050
Sale
Common Stock
5,000
$115.16
$575,800
Option
Common Stock
16,000
$1.87
$29,920
Option
Stock Option (Right to Buy)
16,000
$1.87
$29,920
Sale
Common Stock
25,000
$92.61
$2,315,250
Option
Common Stock
25,000
$8.44
$211,000
Option
Stock Option (Right to Buy)
25,000
$8.44
$211,000
Option
Common Stock
25,000
$8.44
$211,000
Option
Stock Option (Right to Buy)
25,000
$8.44
$211,000
Sale
Common Stock
25,000
$92.61
$2,315,325
Sale
Common Stock
25,000
$92.61
$2,315,325
Sale
Common Stock
18,986
$89.33
$1,695,981
Option
Stock Option (Right to Buy)
10,000
$8.8
$88,000
Sale
Common Stock
18,986
$89.33
$1,695,981
Option
Common Stock
10,000
$8.8
$88,000
Sale
Common Stock
5,000
$8.8
$44,000
Option
Stock Option (Right to Buy)
5,000
$8.8
$44,000
Option
Common Stock
5,000
$8.8
$44,000
Sale
Common Stock
20,000
$98.85
$1,977,000
Option
Stock Option (Right to Buy)
20,000
$8.8
$176,000
Option
Common Stock
20,000
$8.8
$176,000
Option
Common Stock
5,000
$8.8
$44,000
Sale
Common Stock
5,000
$8.8
$44,000
Option
Stock Option (Right to Buy)
5,000
$8.8
$44,000
Option
Common Stock
20,000
$8.8
$176,000
Sale
Common Stock
20,000
$74.97
$1,499,400
Option
Stock Option (Right to Buy)
20,000
$8.8
$176,000
Option
Common Stock
20,000
$8.8
$176,000
Sale
Common Stock
20,000
$64.82
$1,296,340
Option
Stock Option (Right to Buy)
20,000
$8.8
$176,000
Option
Stock Option (Right to Buy)
40,000
$4.18
$167,200
Sale
Common Stock
20,000
$52.89
$1,057,700
Option
Common Stock
40,000
$4.18
$167,200
Sale
Common Stock
2,277
$51.97
$118,336
Sale
Common Stock
8,256
$75.76
$625,475
Option
Common Stock
20,000
$5.34
$106,700
Option
Stock Option (Right to Buy)
20,000
$5.34
$106,700
Sale
Common Stock
11,744
$74.56
$875,633
Option
Common Stock
20,000
$1.87
$37,400
Option
Stock Option (Right to Buy)
20,000
$1.87
$37,400
Option
Stock Option (Right to Buy)
20,000
$1.87
$37,400
Option
Common Stock
20,000
$1.87
$37,400
Sale
Common Stock
20,000
$83.24
$1,664,800
Option
Common Stock
5,000
$1.87
$9,350
Sale
Common Stock
5,000
$1.87
$9,350
Option
Stock Option (Right to Buy)
5,000
$1.87
$9,350
Sale
Common Stock
20,000
$84.13
$1,682,560
Option
Stock Option (Right to Buy)
20,000
$1.87
$37,400
Option
Common Stock
20,000
$1.87
$37,400
Option
Common Stock
20,000
$1.87
$37,400
Option
Stock Option (Right to Buy)
20,000
$1.87
$37,400
Sale
Common Stock
20,000
$86.49
$1,729,740
Option
Stock Option (Right to Buy)
28,961
$1.87
$54,157
Option
Common Stock
28,961
$1.87
$54,157
Option
Stock Option (Right to Buy)
20,000
$1.87
$37,400
Option
Common Stock
20,000
$1.87
$37,400
Sale
Common Stock
20,000
$63.92
$1,278,360
Option
Stock Option (Right to Buy)
20,000
$1.87
$37,400
Sale
Common Stock
20,000
$69.96
$1,399,100
Option
Common Stock
20,000
$1.87
$37,400
Option
Stock Option (Right to Buy)
20,000
$1.87
$37,400
Option
Common Stock
20,000
$1.87
$37,400
Sale
Common Stock
20,000
$78.86
$1,577,100
Option
Stock Option (Right to Buy)
20,000
$1.87
$37,400
Sale
Common Stock
20,000
$91.55
$1,831,020
Option
Common Stock
20,000
$1.87
$37,400
Option
Common Stock
24,514
$1.87
$45,841
Sale
Common Stock
30,000
$71.26
$2,137,800
Option
Stock Option (Right to Buy)
24,514
$1.87
$45,841
Sale
Common Stock
10,000
$50.7
$507,000
Sale
Common Stock
20,000
$48.75
$975,000
Sale
Common Stock
20,000
$50.18
$1,003,540
Sale
Common Stock
20,000
$39.9
$797,900
Sale
Common Stock
17,000
$23.03
$391,510
Sale
Common Stock
17,000
$20.03
$340,510
Sale
Common Stock
17,000
$20.42
$347,140
Sale
Common Stock
7,000
$21.87
$153,090
Sale
Common Stock
10,000
$21.02
$210,200
Blueprint Medicines key executives
Blueprint Medicines Corporation executives and other stock owners filed with the SEC:
